D-limonene is a naturally occurring
monoterpene and has been found to posses numerous therapeutic properties. In this study, we used
D-limonene as a
protective agent against the nephrotoxic effects of anticancer
drug doxorubicin (Dox). Rats were given
D-limonene at doses of 5% and 10% mixed with diet for 20 consecutive days. Dox was give at the dose of 20 mg/kg
body weight intraperitoneally. The protective effects of
D-limonene on Dox-induced oxidative stress and
inflammation were investigated by assaying oxidative stress
biomarkers, lipid peroxidation, serum toxicity markers, proinflammatory
cytokines, and expression of
nuclear factor kappa B (NFκB), cyclo-oxygenase-2 (COX-2), and
inducible nitric oxide synthase (iNOS) and
Nitrite levels. Administration of Dox (20 mg/kg
body weight) in rats enhanced renal lipid peroxidation; depleted
glutathione content and
anti-oxidant enzymes; elevated levels of kidney toxicity markers viz. kidney injury molecule-1 (KIM-1), blood
urea nitrogen (BUN), and
creatinine; enhanced expression of NFκB, COX-2, and iNOS and
nitric oxide. Treatment with
D-limonene prevented oxidative stress by restoring the levels of
antioxidant enzymes, further both doses of 5% and 10% showed significant decrease in inflammatory response. Both the doses of
D-limonene significantly decreased the levels of kidney toxicity markers KIM-1, BUN, and
creatinine.
D-limonene also effectively decreased the Dox induced overexpression of NF-κB, COX-2, and iNOS and
nitric oxide. Data from the present study indicate the protective role of
D-limonene against Dox-induced renal damage.